Showing results (61-70 of 413) with videos related to
Sort By:
Pageof 42
European Journal of Clinical Investigation|February 15, 2011
Effect of weight loss on serum pigment epithelium-derived factor levelsAlexander Tschoner, Wolfgang Sturm, Claudia Ress, et al.Expert Opinion on Therapeutic Targets|April 16, 2008
Novel therapeutic targets in the treatment of IBDArthur Kaser, Herbert TilgWiener Medizinische Wochenschrift (1946)|July 12, 2013
[Management of severe alcoholic hepatitis]Verena Wieser, Herbert TilgExpert Opinion on Biological Therapy|October 22, 2002
Antitumour necrosis factor therapy in Crohn's diseaseHerbert Tilg, Arthur KaserExpert Opinion on Biological Therapy|April 23, 2004
Type I interferons and their therapeutic role in Th2-regulated inflammatory disordersHerbert Tilg, Arthur KaserThe Journal of Clinical Investigation|June 3, 2011
Gut microbiome, obesity, and metabolic dysfunctionHerbert Tilg, Arthur KaserMetabolism: Clinical and Experimental|February 25, 2016
Nonalcoholic fatty liver disease and hepatocellular carcinomaHeinz Zoller, Herbert TilgClinical Immunology (Orlando, Fla.)|September 24, 2004
Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel diseaseAnna Maria Wolf, Dominik Wolf, Holger Rumpold, et al.Viruses|January 26, 2024
B and T Cell Responses to SARS-CoV-2 Vaccination in Kidney and Liver Transplant Recipients with and without Previous COVID-19Christina Watschinger, Gerald Stampfel, Andreas Zollner, et al.Current Opinion in Clinical Nutrition and Metabolic Care|May 18, 2010
Update on nonalcoholic fatty liver disease: genes involved in nonalcoholic fatty liver disease and associated inflammationHerbert Tilg, Alexander MoschenPageof 42